Dr. Matthew Matasar discusses why stem cell transplant is still a standard, life-saving option in blood cancers and how CAR-T ...

Among patients with PD-1/PD-L1-pretreated recurrent/metastatic head and neck squamous cell carcinoma (HNSCC), treatment with ...

Breast cancer survivors highlighted guidance and encouragement they received when first diagnosed, offering reassurance for ...

The boutique offers a wide range of prosthetic breast options, providing a sense of empowerment and choice for survivors. The experience is likened to a toy store, highlighting the playful and ...

ADC usage in breast cancer treatment increased 3.7-fold from 2021 to 2023, with significant reductions in median time to ...

Among patients with operable, newly diagnosed brain metastases, treatment with GammaTile was associated with a greater than 50% reduction in the risk of either tumor recurrence or death compared to ...

Camrelizumab/famitinib combination significantly improved PFS and OS over platinum-based chemotherapy in recurrent/metastatic ...

VCN-01 plus standard chemotherapy and Abraxane proved safe and effective for patients with metastatic pancreatic cancer.

Trodelvy plus Keytruda may maintain QOL and delay physical decline in PD-L1-positive mTNBC patients. The combination therapy showed improved progression-free survival and reduced symptom burden ...

Cancer treatments have evolved, improving survival rates and quality of life, challenging the notion of cancer as a death ...

The cancer vaccine IO102-IO103 plus Keytruda was associated with a clinically relevant improvement in median progression-free ...

Outside prostate cancer, Truqap is FDA-approved with fulvestrant (Faslodex) for patients with hormone receptor-positive, HER2 ...